


Kerri Kaplan
656 posts

@KaplanKerri
President at the @lustgartenfdn, the world's largest private funder of #PancreaticCancer research w/more than $200 million committed to research





Welcome to our newest Bloomberg Distinguished Professor, internationally recognized cancer researcher @megeblad, who joins @JohnsHopkins as the BDP of Tumor Microenvironment. Learn about her work on myeloid cells, neutrophil extracellular traps, & more: hub.jhu.edu/2023/06/27/mik…

ICYMI: Read all about the work of @TheVinodLab.

Since 2001, Lustgarten Walks for Research have united a community of passionate individuals, like the Pipers, determined to transform #pancreaticcancer into a curable disease. Find a Walk today! Lustgarten.org/Walk #MilestoneMonday #CommunityIsPower bit.ly/427eYIT

One of the greatest and inspirational experiences was collaborating with President Jimmy Carter & the @CarterCenter during the formation of @letswinpc, and having President Carter as our honorary board member. Wishing President Carter comfort and peace. 💜💜

A decade into joining Twitter, @mggoggins @hopkinskimmel has sent his first tweet. It’s a really great study in @JCO_ASCO emphasizing the value of surveillance for #PancreaticCancer in high risk cohorts. Worth waiting a decade for this inaugural tweet!

Dr. Jedd Wolchok, an esteemed physician-scientist who pioneered immunotherapy for the treatment of melanoma, is the new director of the @WCM_MeyerCancer. Join us in welcoming him to this leadership role that unites cancer research across the institution. bit.ly/3Biviv9

Dr. Jedd Wolchok, an esteemed physician-scientist who pioneered immunotherapy for the treatment of melanoma, is the new director of the @WCM_MeyerCancer. Join us in welcoming him to this leadership role that unites cancer research across the institution. bit.ly/3Biviv9

Lustgarten Chief Medical Advisor, Dr. Elizabeth Jaffee, has been appointed to President Biden's Cancer Panel, a.k.a. #CancerMoonshot. Liz and others will advise the president on barriers to, and opportunities for, progress in reducing the burden of cancer. bit.ly/3o1XAT1







Here’s why surveillance in high risk cohorts matters: - 83% of individuals were resectable at time of Dx (usual numbers in #PancreaticCancer: 15-20%) - 33% had stage 1 disease (v <5%) - 5y survival rate in resected cancer patients 👉🏽 44% @OncoAlert @lustgartenfdn @letswinpc


The Burroughs Wellcome Fund is pleased to announce the recipients of the 2022 Career Award for Medical Scientists buff.ly/3GGFRZL #bwfcams #bwfrtp









“Anything that I show, anything I have, you can have” - D. Tuveson